Arax Advisory Partners’s Burning Rock Biotech BNR Stock Holding History
Bought
Maintained
Sold
Other funds holding BNR
KCM
Arax Advisory Partners's BNR Position: Q3 2026 in Review
Arax Advisory Partners opened a new position in Burning Rock Biotech (BNR) in Q3 2026: 34 shares worth $599. The stake represents ﹤0.01% of the portfolio and ranks #5106 among its holdings.
17 funds tracked by Wall St. Rank hold BNR as of Q3 2026.
- Arax Advisory Partners held 34 shares of Burning Rock Biotech worth $599 as of Q3 2026.
- Burning Rock Biotech was a new Arax Advisory Partners position in Q3 2026.
- Burning Rock Biotech made up ﹤0.01% of Arax Advisory Partners's portfolio in Q3 2026, its #5106 holding.
- 17 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q3 2026.
Based on Arax Advisory Partners's 13F filing for Q3 2026, filed 12 Nov 2026.